ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102. A total of 55 filers reported holding ONCOMED PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $24,000 | -78.2% | 10,429 | -61.4% | 0.00% | -80.0% |
Q4 2017 | $110,000 | -44.2% | 27,052 | -54.4% | 0.01% | -50.0% |
Q2 2017 | $197,000 | +68.4% | 59,360 | +366.1% | 0.01% | +100.0% |
Q1 2017 | $117,000 | -85.9% | 12,736 | -84.5% | 0.01% | -86.5% |
Q1 2016 | $832,000 | – | 82,313 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 4,108,815 | $4,273,000 | 0.48% |
Birchview Capital, LP | 372,557 | $387,000 | 0.24% |
Perceptive Advisors | 1,719,111 | $1,787,000 | 0.05% |
Fondren Management LP | 25,136 | $26,000 | 0.02% |
Cannell & Co. | 281,983 | $293,000 | 0.01% |
APPLETON PARTNERS INC/MA | 66,206 | $69,000 | 0.01% |
Quinn Opportunity Partners LLC | 66,162 | $69,000 | 0.01% |
NJ State Employees Deferred Compensation Plan | 38,000 | $40,000 | 0.01% |
Candriam S.C.A. | 380,000 | $395,000 | 0.01% |
PRIMECAP MANAGEMENT CO/CA/ | 5,451,400 | $5,669,000 | 0.00% |